|
| |||||||||||||||||||||||||||||||
Although this regimen may not have influenced the outcome in this case, neither ampicillin nor cefotaxime has substantial activity against P. aeruginosa. Gentamicin is characterized by enhanced penetration across the bloodbrain barrier in neonates, but it also may not reach bactericidal levels in the cerebrospinal fluid. Effective treatment of P. aeruginosa meningitis requires high doses of a third-generation cephalosporin with adequate penetration of the cerebrospinal fluid, such as ceftazidime.2 Aminoglycosides may be used as adjunctive treatment in severe cases or if the initial therapy fails or there is a relapse. Other agents that have good in vitro activity and adequate penetration and for which there are reports of clinical success include meropenem,3 ciprofloxacin,4 and aztreonam.5
David W. Wareham, M.B., B.S.
Barts and the London National Health Service Trust
London E1 1BB, United Kingdom
dwareham{at}msn.com
References
To the Editor: We agree that the combination of ampicillin, gentamicin, and cefotaxime should not be promoted as therapy for established P. aeruginosa meningitis. Indeed, we used this combination of antibiotics in our patient only when meningitis was clinically evident, there were findings suggestive of sepsis, and the causative organism had not yet been identified. Our treatment is in complete accordance with general recommendations for the antibiotic treatment of neonates at risk for sepsis.1
Immediately after the identification of P. aeruginosa in the specimens, the antibiotic regimen was altered, and ampicillin was replaced by piperacillin. A further change was initiated when information on the pattern of antibiotic sensitivity was available; treatment was continued with the use of ceftazidime and piperacillin; cefotaxime and gentamicin were withdrawn. Nevertheless, the infecting P. aeruginosa strain was still sensitive to cefotaxime and gentamicin, though we agree that the two drugs may not have substantial activity against P. aeruginosa in the cerebrospinal fluid. Two days after the initiation of the empirical antimicrobial treatment, a cerebrospinal fluid specimen was sterile.
Gerd Döring, Ph.D.
University of Tübingen
D-72074 Tübingen, Germany
gerd.doering{at}uni-tuebingen.de
Matthias Vochem, M.D.
Olgaspital
70176 Stuttgart, Germany
References
| |||||||||||||||||||||||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |